ABSTRACT
Based on the study of 60 women who were treated at the gynecology department of the Novosibirsk Regional Oncology Dispensary from 2003 to 2013 with a diagnosis of primary multiple synchronous and metachronous neoplasia with endometrial lesion it was found that the most common risk factors for this disease could be considered: overweight and obesity; late age at onset of menarche; late age of menopause; concomitant cardiovascular diseases and disorders of the endocrine metabolism.
Subject(s)
Endometrial Neoplasms/diagnosis , Endometrial Neoplasms/epidemiology , Neoplasms, Multiple Primary/diagnosis , Neoplasms, Multiple Primary/epidemiology , Obesity/complications , Adult , Age Factors , Aged , Female , Humans , Menarche , Menopause , Middle Aged , Neoplasms, Second Primary/diagnosis , Neoplasms, Second Primary/epidemiology , Risk Factors , Russia/epidemiologyABSTRACT
UNLABELLED: The aim of this work is to study responses of PHA-stimulated and resting lymphocytes to methylating agent N-methyl-N-nitrosourea (MNU) and to compare sensitivity to this agent of healthy donor lymphocytes and lymphocytes from patients with gynecological cancers. METHODS: Cytotoxicity of MNU, apoptotic death of lymphocytes, was evaluated using two common tests--annexin V-FITC detection assay and live/dead double staining assay (nuclear morphological changes). Genotoxic effect of the agent was determined as delayed (secondary) DNA double strand breaks (DSBs) using neutral comet assay both conventional variant and modified for detection of bromodeoxyuridine-labelled comets, produced by proliferating lymphocytes only. RESULTS: Unstimulated lymphocytes were tolerant to geno- and cytotoxic effects of MNU. In contrast to resting cells, proliferating lymphocytes showed significant genotoxicity (p=0.0054) of MNU followed by increased apoptotic death of cells (p<0.05). Average number of secondary DSBs induced by MNU in lymphocytes from patients with gynecological cancers was about 4-fold less than that of lymphocytes of healthy donors. While lymphocytes from cancer patients did not change proliferative index in response to MNU, the agent decreased 2-fold proliferative indices of stimulated lymphocytes from healthy donors. CONCLUSION: There is a reverse association between geno- and cytotoxicity of MNU in stimulated lymphocytes and the presence of tumor. The relationship appears to be based on MMR-insufficiency in lymphocytes of the cancer patients.
